XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation.

Life Science 105

Life Science Gene Therapy DNA Vaccine 105

Pharmaceutical Technology

JUNE 4, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. Transcription of the cap gene is initiated from a single promoter termed p40.

Gene 262

Gene Gene Therapy Genetics DNA 262

XTalks

OCTOBER 26, 2023

The best way to prevent the flu is by getting vaccinated every year. The CDC and the World Health Organization (WHO) recommend annual flu vaccination for most people, especially those at high risk of serious complications, like pregnant women, elderly individuals, children and people with certain chronic health conditions.

Vaccine 105

Vaccine Vaccination RNA Manufacturing 105

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Genome 244

Genome Genomics Medicine Gene Therapy 244

XTalks

MARCH 1, 2024

International HPV Awareness Day 2024 is an essential call to action for increased education, vaccination uptake and access to screening and treatment services. In addition, some types of HPV vaccines can be given to those older than 26 years of age.

Vaccine 52

Vaccine Vaccination Life Science FDA Approval 52

pharmaphorum

JULY 6, 2021

The new figures – from the BioIndustry Association and Clarivate – were dominated by more than £1 billion in venture capital funding for UK biotech and life sciences companies, headlined by DNA sequencing company Oxford Nanopore’s £195 million raise in May that was just shy of the £205 million record set by Immunocore in 2005.

Life Science 141

Life Science Gene Therapy DNA Gene 141

Pharmaceutical Technology

MAY 15, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Life Science 162

Life Science DNA Antibody Development 162

Delveinsight

JULY 29, 2020

Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus. India’s COVID-19 vaccine candidates.

Vaccine 62

Vaccine Vaccination Clinical Trials Clinical Trials 62

XTalks

MAY 17, 2024

Every year on May 18th, the global community commemorates World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day. Led by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), World AIDS Vaccine Day emphasizes the importance of awareness and education in the fight against HIV/AIDS.

Vaccine 52

Vaccine Vaccination Research Immune Response 52

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccine Vaccination 98

pharmaphorum

FEBRUARY 3, 2021

The data show that 2020 was a “watershed year” for UK biotech , according to BIA chief executive Steve Bates, who said the uplift was seen across the life sciences category, not just organisations that were directly involved in the COVID-19 response.

Life Science 111

Life Science DNA Development Vaccine 111

pharmaphorum

JANUARY 30, 2022

2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. “History has handed the UK two world-leading sectors: life sciences and finance.

Life Science 98

Life Science Allergies DNA Licensing 98

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

XTalks

SEPTEMBER 30, 2020

The team sequenced DNA from 659 critically ill COVID-19 patients and 534 controls with mild or asymptomatic disease. People with the autoantibodies could be advised to take extra precautionary measures against exposure to COVID-19, or be prioritized for vaccination, said Zuniga. The analysis revealed that 23 (3.5

Antibody 135

Antibody Genetics Research In-Vitro 135

pharmaphorum

AUGUST 31, 2022

It seems the FDA is trying to get ahead of any scepticism about gene therapies that proved complicated when encouraging uptake of COVID-19 vaccines. The technology operates through mobile genetic elements (MGEs), which are segments of DNA that code enzymes and proteins to move DNA within the genome. A broadening pipeline.

Gene Therapy 98

Gene Therapy Gene Gene Editing DNA 98

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Antibody 246

Antibody Vaccine Vaccination Dermatology 246

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Drugs 130

Drugs Antibody Life Science DNA 130

pharmaphorum

OCTOBER 12, 2022

The payload, Del Bourgo tell us, is the therapeutic DNA or RNA sequence that will cure or fix damaged cells. Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. “This is just the beginning; the potential is enormous,” he says.

Genome 105

Genome Genomics Medicine Development 105

XTalks

NOVEMBER 30, 2023

The noteworthy candidate, EBT-101, is designed to eliminate HIV proviral DNA using CRISPR-Cas9 along with two guide RNAs (gRNAs). These dual gRNAs target three specific sites within the HIV genome, facilitating the removal of substantial portions of the viral DNA and minimizing the potential for viral escape.

FDA Approval 111

FDA Approval Gene Therapy Clinical Trials Clinical Trials 111

XTalks

MARCH 10, 2021

Along with COVID-19 vaccine authorizations, the US Food and Drug Administration (FDA) remains committed to increasing access to COVID-19 tests and supporting their development, having authorized three new tests recently for emergency use. The products encompass molecular, antigen and T cell-based testing approaches.

Protein 98

Protein RNA Antibody Production 98

XTalks

FEBRUARY 12, 2024

In the commercial, Pfizer highlighted some of its major scientific offerings throughout the centuries, which include contributions to the mass production of penicillin and creating COVID-19 vaccines. In 2023, alone, the company said its medicines and vaccines reached more than 1.3

Scientist 105

Scientist DNA Vaccine Vaccination 105

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Antibody 147

Antibody Vaccine Vaccination Dermatology 147

XTalks

AUGUST 12, 2020

Xtalks spoke to lead author on the study, Mohamed Abdel-Mohsen, PhD, assistant professor, Vaccine & Immunotherapy Center at the Wistar Institute, about the emerging utility of identifying glycomic, or sugar, signatures on the surface of immune cells to help in their identification and potential targeting.

RNA 52

RNA Protein DNA In-Vivo 52

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These can serve as an important component of a vaccine.

Protein 147

Protein Vaccine Vaccination Production 147

XTalks

DECEMBER 13, 2023

Related: Top 30 Pharma Companies in 2023: Statistics and Trends 1) Moderna Compound annual growth rate: 415 percent Moderna, headquartered in Massachusetts, is a prominent biotechnology company specializing in RNA therapeutics, particularly mRNA vaccines. vaccine, mRNA-1273.815.

Genetics 111

Genetics Vaccine Vaccination DNA 111

XTalks

OCTOBER 8, 2024

A gene contains instructions within our DNA. Once in the shadows of DNA, interest in RNA has been increasing within both scientific and public circles. Hungarian scientist Katalin Kariko and US colleague Drew Weissman shared the 2023 prize for developing mRNA technology that led to the mRNA COVID-19 vaccines.

Regulation 52

Regulation Genetics Scientist RNA 52

pharmaphorum

AUGUST 27, 2020

The Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), works with universities, research organisations, businesses, charities, and government to develop a supportive ecosystem. The first is that the development of vaccines is utilising cutting edge technologies.

Vaccine 122

Vaccine Vaccination Life Science Clinical Trials 122

The Pharma Data

JANUARY 5, 2021

This will empower public and private entities to react quickly to any potential changes in pathogenicity of the virus or effectiveness of diagnostics, therapeutics, and vaccines. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. About Illumina.

Genome 52

Genome Genomics Life Science Development 52

XTalks

MARCH 23, 2022

The ad highlights Exact Sciences’ Cologuard, a DNA-based stool test for colon cancer detection. The editorial team also learned about Alnylam Pharmaceuticals’ lawsuits against mRNA COVID-19 vaccine makers Pfizer and Moderna over patent infringements. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science RNA Vaccine Vaccination 52

XTalks

MARCH 31, 2021

A new report from the Center for Countering Digital Hate (CCDH) and Anti-Vax Watch has identified 12 individuals, dubbed the “Disinformation Dozen,” as being responsible for spreading up to 65 percent of all online anti-vaccine information. The Disinformation Dozen includes influential anti-vax leaders such as Robert F. Kennedy Jr.,

Vaccine 75

Vaccine Vaccination DNA Doctors 75

XTalks

JULY 20, 2022

million state-of-the-art mRNA vaccine and biomanufacturing facility, making it one of the first in the country. The cutting-edge plant will be dedicated to the manufacturing of mRNA vaccines and therapeutics. Related: Biovectra to Build First mRNA Vaccine and Drug Manufacturing Plant in Canada. Learn more! In addition to a $39.8

Vaccine 105

Vaccine Vaccination Manufacturing Life Science 105

Pharmaceutical Technology

NOVEMBER 22, 2022

Vaccines are our number one weapon in the fight against infectious diseases, but their development has historically involved a long and complex process taking up to a decade. Before COVID-19, Merck held the record for the fastest modern vaccine ever developed. mRNA’s potential for rapid vaccine delivery.

Manufacturing 130

Manufacturing Vaccine Vaccination RNA 130

XTalks

JUNE 20, 2022

XTALKS WEBINAR: Liquid Biopsy Workflow Optimization for Improved Assay Sensitivity and Multianalyte Applications of Cell-Free RNA, DNA and CTCs. The featured speaker will discuss the need of standardized workflows as well as the need for blood stabilization for circulating cell-free DNA (ccfDNA) analysis and impact on assay sensitivity.

FDA Approval 98

FDA Approval Protein Genetics RNA 98

XTalks

AUGUST 2, 2023

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

FEBRUARY 17, 2022

Monitoring allows researchers to understand previous evolutionary events and predict how viruses may change in the future, allowing for a better understanding of virulence evolution, drug resistance, and vaccine efficacy. WGS is largely used in research studies as it allows for the analysis of complete genomes of various bacterial pathogens.

Genome 98

Genome Genomics Genetics Genotype 98

Pharmaceutical Technology

FEBRUARY 20, 2023

During the pandemic, Teddy Lab Wuxi have supported over dozens of COVID drug or vaccine clinical trials, many of which are working closely with Cerba Research, and as a result, multiple candidates have been approved under emergency use in different countries. Teddy Lab also reached multiple milestones in the past 5 years.

Research 130

Research Clinical Trials Clinical Trials Clinical Research 130

Delveinsight

SEPTEMBER 2, 2021

In this case, Delfi is developing a highly sensitive and specific assay intended for comprehensive and cost-effective distribution and adoption by utilizing an advanced machine learning algorithm to the circulating DNA fragment patterns, which can be evaluated through low-cost sequencing.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72